Work Area: Licensing

Latest content

IoT semiconductor firm to offer Nokia patent licence to customers

Through a new partnership with the top patent owner in cellular IoT, Nordic Semiconductor hopes to give connected device makers better upfront visibility of IP licensing costs

27 January 2022

Ericsson banks $875 million in IP licensing revenues for 2021

Despite 19% year-on-year drop in royalty receipts, the Swedish company’s cash position has never been better as it digs in for global litigation battle with Apple

26 January 2022

AstraZeneca continues its winning out-licensing/in-licensing strategy

The Anglo-Swedish company has been a trailblazer in the monetisation of deprioritised IP

21 January 2022

Ex-Samsung IP head’s involvement in NPE suit raises eyebrows

Court filings show Seungho Ahn, who led the Korean tech giant’s IP function until 2019, is closely involved in a patent assertion against his former employer

21 January 2022

We should fight it out with Ericsson in Texas, Apple tells the ITC

Case filed yesterday by the iPhone giant makes clear that it wants its patent licensing dispute with the Swedish company to centre on the US court system

20 January 2022

For Taiwan firms, the time is now for patent monetisation

Recent moves by MediaTek, Asus and Acer all show that IP owners are seeking to boost returns

20 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

Landmark Dusseldorf non-FRAND finding is big news for joint licensing programmes

SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling

13 January 2022

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

11 January 2022

Get unlimited access to all IAM content